SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
SOPHiA GENETICS SA (SOPH) Misses Q4 EPS by 15c, Misses on Revenue; Offers FY24 Revenue Guidance
March 5, 2024 6:48 AM ESTSOPHiA GENETICS SA (NASDAQ: SOPH) reported Q4 EPS of ($0.37), $0.15 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $17 million versus the consensus estimate of $17.33 million.
GUIDANCE:
SOPHiA GENETICS SA sees FY2024 revenue of $78-81 million, versus the... More



